Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 10, Issue 4, Pages 471-486
Publisher
Informa UK Limited
Online
2011-04-20
DOI
10.1586/erv.11.29
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans
- (2014) Kenneth Von Eschen et al. Human vaccines & immunotherapeutics
- An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers
- (2011) Eva Van Braeckel et al. CLINICAL INFECTIOUS DISEASES
- Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine
- (2011) Tino F. Schwarz et al. Human vaccines & immunotherapeutics
- Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists
- (2010) Matthew Black et al. Expert Review of Vaccines
- Letter from the Editor
- (2010) Ronald W. Ellis et al. Human vaccines & immunotherapeutics
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine
- (2010) Michel Deschuyteneer et al. Human vaccines & immunotherapeutics
- Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults
- (2010) Jiří Beran et al. Human vaccines & immunotherapeutics
- From the circumsporozoite protein to the RTS,S/AS candidate vaccine
- (2010) Joe Cohen et al. Human vaccines & immunotherapeutics
- From Vaccines to Memory and Back
- (2010) Federica Sallusto et al. IMMUNITY
- Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
- (2010) M. Juliana McElrath et al. IMMUNITY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Immunogenicity, Reactogenicity, and Safety of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women
- (2010) Ryo Konno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Efficacy of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years
- (2010) Ryo Konno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Efficacy of Human Papillomavirus Type 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years
- (2010) Ryo Konno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls
- (2010) Doris M. Rivera Medina et al. JOURNAL OF ADOLESCENT HEALTH
- Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis–inactivated Poliovirus Vaccine to Girls and Young Women
- (2010) José Garcia-Sicilia et al. JOURNAL OF ADOLESCENT HEALTH
- Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years
- (2010) Young-Jae Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women
- (2010) Neerja Bhatla et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- New vaccines for tuberculosis
- (2010) Stefan HE Kaufmann et al. LANCET
- Immunology and the elusive AIDS vaccine
- (2010) Herbert W. Virgin et al. NATURE
- Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
- (2010) Mahamadou A. Thera et al. PLoS One
- The Population Dynamics and Control of Tuberculosis
- (2010) C. Dye et al. SCIENCE
- Tuberculosis: What We Don't Know Can, and Does, Hurt Us
- (2010) D. G. Russell et al. SCIENCE
- Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
- (2010) N. De Carvalho et al. VACCINE
- Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
- (2010) Jaap T. van Dissel et al. VACCINE
- Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
- (2010) Isabel Leroux-Roels et al. VACCINE
- Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
- (2009) Tino F. Schwarz ADVANCES IN THERAPY
- Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers
- (2009) Olivier Lambotte et al. AIDS
- Human B cell memory
- (2009) Antonio Lanzavecchia et al. CURRENT OPINION IN IMMUNOLOGY
- New concepts in herpes simplex virus vaccine development: notes from the battlefield
- (2009) Gargi Dasgupta et al. Expert Review of Vaccines
- Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆
- (2009) Marie-Pierre David et al. GYNECOLOGIC ONCOLOGY
- The ABC of clinical and experimental adjuvants—A brief overview
- (2009) Richard Brunner et al. IMMUNOLOGY LETTERS
- Plasmodium falciparum-Specific Cellular Immune Responses after Immunization with the RTS,S/AS02D Candidate Malaria Vaccine in Infants Living in an Area of High Endemicity in Mozambique
- (2009) A. Barbosa et al. INFECTION AND IMMUNITY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Long‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
- (2009) Jahit Sacarlal et al. JOURNAL OF INFECTIOUS DISEASES
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
- (2009) Kent E. Kester et al. JOURNAL OF INFECTIOUS DISEASES
- Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02V-adjuvanted hepatitis B vaccine
- (2009) Murielle Surquin et al. KIDNEY INTERNATIONAL
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer
- (2009) Catherine Gérard et al. Molecular Oncology
- Maternal and Neonatal Herpes Simplex Virus Infections
- (2009) Lawrence Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
- (2009) Bernhards R. Ogutu et al. PLoS One
- Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
- (2009) Michele D. Spring et al. PLoS One
- Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
- (2009) Caterina Guinovart et al. PLoS One
- Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
- (2009) Mark E. Polhemus et al. PLoS One
- Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
- (2009) John N. Waitumbi et al. PLoS One
- A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
- (2009) Bertrand Lell et al. PLoS One
- The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial
- (2009) Régine Audran et al. PLoS One
- Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
- (2009) Seth Owusu-Agyei et al. PLoS One
- Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
- (2009) S. G. Reed et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys
- (2009) S. Pichyangkul et al. VACCINE
- Development of the RTS,S/AS malaria candidate vaccine
- (2009) Johan Vekemans et al. VACCINE
- Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection
- (2009) James F. Cummings et al. VACCINE
- Papillomaviruses in the causation of human cancers — a brief historical account
- (2009) Harald zur Hausen VIROLOGY
- Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?
- (2009) David C Montefiori et al. Current Opinion in HIV and AIDS
- Monocyte-Mediated Defense Against Microbial Pathogens
- (2008) Natalya V. Serbina et al. Annual Review of Immunology
- Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities
- (2008) F. Eddahri et al. BLOOD
- An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
- (2008) Katharine Looker BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cellular effector mechanisms againstPlasmodiumliver stages
- (2008) Ute Frevert et al. CELLULAR MICROBIOLOGY
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease
- (2008) Vincent G Brichard et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients
- (2008) Jiri Beran EXPERT OPINION ON BIOLOGICAL THERAPY
- Plasmodium falciparummalaria vaccines in development
- (2008) Johan Vekemans et al. Expert Review of Vaccines
- AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention
- (2008) Tino F Schwarz Expert Review of Vaccines
- Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature
- (2008) Tino F. Schwarz et al. GYNECOLOGIC ONCOLOGY
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years
- (2008) Tiina Petäjä et al. JOURNAL OF ADOLESCENT HEALTH
- Malaria: progress, perils, and prospects for eradication
- (2008) Brian M. Greenwood et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian human immunodeficiency virus viraemia with protein/DNA combination
- (2008) G. Koopman et al. JOURNAL OF GENERAL VIROLOGY
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
- (2008) Jens Wrammert et al. NATURE
- Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
- (2008) Philip Bejon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
- (2008) Salim Abdulla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
- (2008) Mahamadou A. Thera et al. PLoS One
- Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
- (2008) Meta Roestenberg et al. PLoS One
- Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming
- (2008) D. Atanackovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
- (2008) Kent E. Kester et al. VACCINE
- Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women
- (2008) Troy J. Kemp et al. VACCINE
- Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
- (2008) Thomas Verstraeten et al. VACCINE
- Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen
- (2008) Pascal Mettens et al. VACCINE
- Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
- (2008) Pierre Vandepapelière et al. VACCINE
- Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years
- (2008) Tino F. Schwarz et al. VACCINE
- A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients
- (2007) N.C.T. Kong et al. KIDNEY INTERNATIONAL
- Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial
- (2007) Jahit Sacarlal et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now